New Insights Into Immunological Therapy for Retinal Disorders.

diabetic retinopathy immune privilege non-infectious uveitis retinitis pigmentosa retinopathy of prematurity vitreoretinal lymphoma

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2020
Historique:
received: 11 03 2020
accepted: 03 06 2020
entrez: 29 7 2020
pubmed: 29 7 2020
medline: 7 4 2021
Statut: epublish

Résumé

In the twentieth century, a conspicuous lack of effective treatment strategies existed for managing several retinal disorders, including age-related macular degeneration; diabetic retinopathy (DR); retinopathy of prematurity (ROP); retinitis pigmentosa (RP); uveitis, including Behçet's disease; and vitreoretinal lymphoma (VRL). However, in the first decade of this century, advances in biomedicine have provided new treatment strategies in the field of ophthalmology, particularly biologics that target vascular endothelial growth factor or tumor necrosis factor (TNF)-α. Furthermore, clinical trials on gene therapy specifically for patients with autosomal recessive or X-linked RP have commenced. The overall survival rates of patients with VRL have improved, owing to earlier diagnoses and better treatment strategies. However, some unresolved problems remain such as primary or secondary non-response to biologics or chemotherapy, and the lack of adequate strategies for treating most RP patients. In this review, we provide an overview of the immunological mechanisms of the eye under normal conditions and in several retinal disorders, including uveitis, DR, ROP, RP, and VRL. In addition, we discuss recent studies that describe the inflammatory responses that occur during the course of these retinal disorders to provide new insights into their diagnosis and treatment.

Identifiants

pubmed: 32719682
doi: 10.3389/fimmu.2020.01431
pmc: PMC7348236
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1431

Informations de copyright

Copyright © 2020 Takeda, Yanai, Murakami, Arima and Sonoda.

Références

Immunol Med. 2019 Jun;42(2):79-83
pubmed: 31315546
Science. 2010 Nov 5;330(6005):841-5
pubmed: 20966214
N Engl J Med. 2006 Oct 5;355(14):1419-31
pubmed: 17021318
Front Immunol. 2016 Feb 08;7:37
pubmed: 26904026
Clin Ophthalmol. 2019 Feb 14;13:353-364
pubmed: 30858685
Ophthalmology. 2013 Jan;120(1):e5-12
pubmed: 22986110
Surv Ophthalmol. 2016 Jan-Feb;61(1):1-17
pubmed: 26164736
Cancer. 2005 Aug 1;104(3):591-7
pubmed: 15973665
Nat Rev Immunol. 2008 Jul;8(7):523-32
pubmed: 18566595
Ocul Immunol Inflamm. 2009 Mar-Apr;17(2):69-72
pubmed: 19412864
Am J Ophthalmol. 2019 Oct;206:176-183
pubmed: 30959004
Prog Retin Eye Res. 2013 Mar;33:10-27
pubmed: 23108335
J Cell Mol Med. 2019 Mar;23(3):1827-1839
pubmed: 30548211
PLoS One. 2019 Jul 23;14(7):e0219405
pubmed: 31335861
Neuron. 2015 Jul 1;87(1):47-62
pubmed: 26139369
Cancer Sci. 2016 Oct;107(10):1458-1464
pubmed: 27412324
Br J Haematol. 2017 Oct;179(2):246-255
pubmed: 28699673
Nat Immunol. 2017 Jan;18(1):74-85
pubmed: 27893700
J Exp Med. 2003 Jul 7;198(1):161-71
pubmed: 12835481
Nat Med. 2007 Jun;13(6):711-8
pubmed: 17496900
Invest Ophthalmol Vis Sci. 2009 Jan;50(1):263-72
pubmed: 18775867
Diabetes Res Clin Pract. 2014 Feb;103(2):137-49
pubmed: 24630390
Nat Med. 2007 Oct;13(10):1155-9
pubmed: 17917664
Lancet. 1991 Oct 19;338(8773):969-73
pubmed: 1681341
Prog Retin Eye Res. 2019 Dec 30;:100827
pubmed: 31899291
J Biol Chem. 2012 Jan 13;287(3):1642-8
pubmed: 22074929
Curr Stem Cell Res Ther. 2014 Mar;9(2):124-33
pubmed: 24350910
Ophthalmology. 2019 Sep;126(9):1273-1285
pubmed: 31443789
Invest Ophthalmol Vis Sci. 2018 May 1;59(6):2659-2669
pubmed: 29847672
Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11300-5
pubmed: 16849425
J Leukoc Biol. 2003 Aug;74(2):161-6
pubmed: 12885931
Biol Open. 2017 Apr 15;6(4):449-462
pubmed: 28258056
Graefes Arch Clin Exp Ophthalmol. 2018 Aug;256(8):1469-1477
pubmed: 29948178
Trends Immunol. 2003 Feb;24(2):77-81
pubmed: 12547504
Nature. 2000 Feb 3;403(6769):503-11
pubmed: 10676951
Surv Ophthalmol. 2018 Nov - Dec;63(6):769-781
pubmed: 29551596
Cell Rep. 2018 May 29;23(9):2629-2642
pubmed: 29847794
EMBO Mol Med. 2015 Jul 02;7(9):1179-97
pubmed: 26139610
Int Immunol. 2008 Feb;20(2):209-14
pubmed: 18156624
Blood. 2015 Jul 2;126(1):76-9
pubmed: 25900979
Jpn J Ophthalmol. 2009 May;53(3):209-14
pubmed: 19484437
Blood. 1997 Feb 1;89(3):941-7
pubmed: 9028325
Br J Ophthalmol. 2005 Apr;89(4):513-7
pubmed: 15774935
Sci Rep. 2019 Nov 15;9(1):16941
pubmed: 31729418
N Engl J Med. 2011 Feb 17;364(7):603-15
pubmed: 21323540
Spine J. 2020 Jan;20(1):138-149
pubmed: 31442616
Ophthalmology. 2003 Feb;110(2):421-6
pubmed: 12578791
Lancet. 2019 Oct 26;394(10208):1551-1559
pubmed: 31522845
Invest Ophthalmol Vis Sci. 2012 Aug 09;53(9):5395-402
pubmed: 22789925
Prog Retin Eye Res. 2018 Jan;62:24-37
pubmed: 28962928
PLoS One. 2015 Sep 22;10(9):e0138241
pubmed: 26393358
Prog Retin Eye Res. 2020 Jan;74:100778
pubmed: 31505218
Diabetes Care. 2005 Feb;28(2):445-7
pubmed: 15677814
Medicine (Baltimore). 2007 Jul;86(4):242-51
pubmed: 17632266
Jpn J Ophthalmol. 2018 May;62(3):398-406
pubmed: 29572578
J Immunol. 2006 May 15;176(10):6323-32
pubmed: 16670344
Ophthalmology. 2014 Oct;121(10):1877-84
pubmed: 24950593
Haematologica. 2016 May;101(5):531-40
pubmed: 27132279
Ophthalmology. 2013 Jan;120(1):100-5
pubmed: 22986109
Proc Natl Acad Sci U S A. 2019 May 14;116(20):9989-9998
pubmed: 31023885
Invest Ophthalmol Vis Sci. 2015 Jul;56(8):4767-77
pubmed: 26218904
Acta Ophthalmol. 2018 Mar;96(2):e174-e179
pubmed: 28636270
Sci Rep. 2017 Oct 16;7(1):12895
pubmed: 29038541
Nat Rev Immunol. 2011 Oct 25;11(11):750-61
pubmed: 22025054
Cytokine. 2020 Mar;127:154943
pubmed: 31810025
Science. 1995 Nov 17;270(5239):1189-92
pubmed: 7502042
Arch Ophthalmol. 2012 May;130(5):592-8
pubmed: 22652845
Immunol Lett. 2019 May;209:4-10
pubmed: 30926373
Autoimmun Rev. 2014 Feb;13(2):138-50
pubmed: 24120737
Proc Biol Sci. 2015 Dec 22;282(1821):20143085
pubmed: 26702035
Br J Haematol. 2016 Jun;173(5):680-92
pubmed: 27133587
Invest Ophthalmol Vis Sci. 2011 Jun 01;52(6):3825-31
pubmed: 21310909
JAMA. 2004 Feb 11;291(6):704-10
pubmed: 14871913
Prog Retin Eye Res. 2019 Sep;72:100758
pubmed: 31014973
Int Ophthalmol. 2014 Apr;34(2):365-81
pubmed: 23729309
J Immunol. 2012 Feb 1;188(3):1191-200
pubmed: 22219322
Diabetes. 2006 Sep;55(9):2401-11
pubmed: 16936187
Ophthalmology. 2016 Nov;123(11):2376-2385
pubmed: 27651226
J Cell Biochem. 2016 Nov;117(11):2443-53
pubmed: 27128219
Cell. 2015 May 7;161(4):817-32
pubmed: 25957687
Eur J Haematol. 2019 Feb;102(2):191-196
pubmed: 30390359
Neurology. 2015 Jan 20;84(3):325-6
pubmed: 25527263
J Exp Med. 2015 Sep 21;212(10):1739-52
pubmed: 26347474
Nat Immunol. 2009 Mar;10(3):241-7
pubmed: 19221555
Am J Pathol. 2010 Nov;177(5):2659-70
pubmed: 20829433
Ann Rheum Dis. 2007 Feb;66(2):253-6
pubmed: 16793840
Sci Rep. 2016 Sep 22;6:33921
pubmed: 27653207
Prog Retin Eye Res. 2013 May;34:19-48
pubmed: 23416119
Blood. 2017 Jun 8;129(23):3071-3073
pubmed: 28356247
Br J Ophthalmol. 2015 Apr;99(4):451-6
pubmed: 25281471
Br J Ophthalmol. 2017 Nov;101(11):1518-1523
pubmed: 28270488
Nat Rev Immunol. 2003 Nov;3(11):879-89
pubmed: 14668804
J Cell Physiol. 2005 Jun;203(3):457-64
pubmed: 15744744
Curr Eye Res. 2013 Jan;38(1):174-9
pubmed: 22906118
Neuro Oncol. 2019 Feb 19;21(3):306-313
pubmed: 30423172
Autoimmun Rev. 2015 Feb;14(2):127-39
pubmed: 25449681
Semin Hematol. 2015 Apr;52(2):67-76
pubmed: 25805586
Cancer Cell. 2019 Sep 16;36(3):250-267.e9
pubmed: 31526758
FASEB J. 2014 May;28(5):2038-46
pubmed: 24571922
Am J Ophthalmol. 2005 Nov;140(5):822-829
pubmed: 16310459
Br J Ophthalmol. 1993 Nov;77(11):731-3
pubmed: 8280690
Ophthalmology. 2009 Jan;116(1):73-9
pubmed: 19118698
Front Oncol. 2019 Mar 07;9:109
pubmed: 30899698
Ocul Immunol Inflamm. 2010 Dec;18(6):488-92
pubmed: 21091058
Front Immunol. 2012 Sep 21;3:296
pubmed: 23049533
Diabetologia. 2005 Jul;48(7):1300-6
pubmed: 15918015
Int Rev Immunol. 2002 Mar-Jun;21(2-3):123-52
pubmed: 12424840
Curr Diabetes Rev. 2007 Feb;3(1):3-14
pubmed: 18220651
Lab Invest. 2012 Jan;92(1):91-101
pubmed: 21912378
Cancer Immunol Immunother. 2009 May;58(5):687-97
pubmed: 18828017
Trans Am Ophthalmol Soc. 2004;102:233-48; discussion 248-50
pubmed: 15747762
Cancer Control. 1998 Jul;5(4):317-325
pubmed: 10761081
Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1701-10
pubmed: 17389502
J Immunol. 2009 Oct 15;183(8):5013-22
pubmed: 19801522
Trans Am Ophthalmol Soc. 2012 Dec;110:117-29
pubmed: 23818738
Exp Eye Res. 2007 Jan;84(1):82-91
pubmed: 17069800
Ann Oncol. 2019 Apr 1;30(4):621-628
pubmed: 30698644
Front Cell Neurosci. 2013 Apr 17;7:45
pubmed: 23616747
Ophthalmology. 2018 May;125(5):757-773
pubmed: 29310963
Glia. 2016 Sep;64(9):1479-91
pubmed: 27314452
Am J Ophthalmol. 2015 May;159(5):958-63.e1
pubmed: 25677184
Lancet. 2013 Oct 26;382(9902):1445-57
pubmed: 23782686
Eur J Cancer. 2019 Aug;117:121-130
pubmed: 31279304
Br J Ophthalmol. 2019 Apr;103(4):475-480
pubmed: 29858180
FASEB J. 2014 Jan;28(1):131-42
pubmed: 24022401
Invest Ophthalmol Vis Sci. 2012 Jun 28;53(7):4323-8
pubmed: 22661475
Oncotarget. 2017 Jan 31;8(5):7989-7998
pubmed: 28002793
J Immunol. 2001 Jan 1;166(1):42-50
pubmed: 11123275
Acta Ophthalmol. 2011 Mar;89(2):e149-54
pubmed: 19958292
Sci Adv. 2018 Mar 21;4(3):eaap8492
pubmed: 29750189
Surv Ophthalmol. 2014 Sep-Oct;59(5):503-16
pubmed: 24560125
Graefes Arch Clin Exp Ophthalmol. 2019 May;257(5):1029-1036
pubmed: 30868235
Lancet. 2006 Nov 18;368(9549):1795-809
pubmed: 17113430
Discov Med. 2013 Feb;15(81):93-100
pubmed: 23449111
Pediatr Res. 2013 Dec;74 Suppl 1:35-49
pubmed: 24366462
JCI Insight. 2016 Sep 22;1(15):e87781
pubmed: 27699246
Curr Rheumatol Rep. 2016 Feb;18(2):12
pubmed: 26943351
Eur J Immunol. 1996 Mar;26(3):659-68
pubmed: 8605935
Am J Ophthalmol. 1988 Jun 15;105(6):596-602
pubmed: 3377040
Eye (Lond). 2008 Feb;22(2):289-93
pubmed: 17767143
Jpn J Ophthalmol. 2015 Nov;59(6):401-8
pubmed: 26318435
Blood. 2019 Aug 22;134(8):709-712
pubmed: 31292111
Arch Ophthalmol. 2009 Apr;127(4):514-9
pubmed: 19365033
Am J Pathol. 2018 Apr;188(4):1007-1020
pubmed: 29452101
Curr Opin Immunol. 2014 Apr;27:1-7
pubmed: 24413387
Clin Exp Rheumatol. 2014 Jul-Aug;32(4 Suppl 84):S149-55
pubmed: 25268669
Nat Neurosci. 2005 Jun;8(6):752-8
pubmed: 15895084
Blood. 2000 Nov 15;96(10):3569-77
pubmed: 11071656
Arch Ophthalmol. 1997 Sep;115(9):1157-60
pubmed: 9298057
Blood. 2016 Feb 18;127(7):869-81
pubmed: 26702065
J Clin Oncol. 2008 May 20;26(15):2512-8
pubmed: 18413641
J Immunol. 2011 Oct 15;187(8):4170-7
pubmed: 21918194
J Leukoc Biol. 2018 Feb 12;:
pubmed: 29431864
Front Immunol. 2017 Nov 30;8:1686
pubmed: 29250068
Mediators Inflamm. 2015;2015:671417
pubmed: 26078494
Jpn J Ophthalmol. 2012 Jul;56(4):383-9
pubmed: 22661396
J Clin Invest. 2017 Nov 1;127(11):3987-4000
pubmed: 28990934
Proc Natl Acad Sci U S A. 2018 Nov 27;115(48):E11359-E11368
pubmed: 30442669
Immunology. 2005 Nov;116(3):390-9
pubmed: 16236129
Retina. 2011 Feb;31(2):222-8
pubmed: 21240043
Invest Ophthalmol Vis Sci. 2012 Jun 28;53(7):4158-69
pubmed: 22562518
J Immunol. 2006 Jan 1;176(1):118-27
pubmed: 16365402
Dev Ophthalmol. 2010;46:4-20
pubmed: 20703029
JAMA Ophthalmol. 2018 Apr 1;136(4):382-388
pubmed: 29522144
Ophthalmology. 2009 Nov;116(11):2165-9
pubmed: 19700197
Nature. 2007 Sep 27;449(7161):419-26
pubmed: 17898760
Ophthalmology. 2016 Jul;123(7):1595-600
pubmed: 27084562
Neuro Oncol. 2012 Jan;14(1):101-8
pubmed: 22013168
Diabetes Care. 2016 Sep;39(9):1643-9
pubmed: 27555623
Immune Netw. 2011 Dec;11(6):399-405
pubmed: 22346781
Orphanet J Rare Dis. 2012 Aug 29;7:57
pubmed: 22932001
Gastroenterology. 2004 Feb;126(2):402-13
pubmed: 14762776
J Exp Med. 2009 Dec 21;206(13):3015-29
pubmed: 20008522
J Exp Med. 2008 Apr 14;205(4):799-810
pubmed: 18391061
Diagn Pathol. 2016 Mar 17;11:29
pubmed: 26987877
Invest Ophthalmol Vis Sci. 2015 Nov;56(12):7516-23
pubmed: 26595610
JAMA. 2015 Sep 8;314(10):1039-51
pubmed: 26348753
Blood. 2001 Feb 1;97(3):587-600
pubmed: 11157473
J Immunol. 2015 Apr 1;194(7):3011-9
pubmed: 25716996
J Leukoc Biol. 2005 Apr;77(4):496-502
pubmed: 15647326
Dev Cell. 2009 Feb;16(2):209-21
pubmed: 19217423
Am J Pathol. 2017 Jan;187(1):9-19
pubmed: 27846381
Blood. 2016 Jul 7;128(1):32-6
pubmed: 27207798
JAMA Ophthalmol. 2016 Mar;134(3):278-85
pubmed: 26746868
Leukemia. 2004 Mar;18(3):597-606
pubmed: 14712288
Am J Ophthalmol. 1997 Sep;124(3):362-72
pubmed: 9439362
Prog Retin Eye Res. 2018 Jul;65:107-126
pubmed: 29496590
Ann Hematol. 2015 Mar;94(3):409-14
pubmed: 25217230
JAMA. 2011 Apr 13;305(14):1460-8
pubmed: 21486979
Science. 1996 May 3;272(5262):735-8
pubmed: 8614837
Trans Am Ophthalmol Soc. 2003;101:275-92
pubmed: 14971583
Lancet. 2010 Jul 10;376(9735):124-36
pubmed: 20580421
Exp Eye Res. 2016 Dec;153:79-89
pubmed: 27720708

Auteurs

Atsunobu Takeda (A)

Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Department of Ophthalmology, Clinical Research Institute, Kyushu Medical Center, National Hospital Organization, Fukuoka, Japan.

Ryoji Yanai (R)

Department of Ophthalmology, Graduate School of Medicine, Yamaguchi University, Yamaguchi, Japan.

Yusuke Murakami (Y)

Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Mitsuru Arima (M)

Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Koh-Hei Sonoda (KH)

Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH